Publications

Human embryonic stemcell-derived test systems for developmental neurotoxicity: a transcriptomics approach

Krug AK, Kolde R, Gaspar JA, Rempel E, Balmer NV, Meganathan K, Vojnits K, Baquié M, Waldmann T, Ensenat-Waser R, Jagtap S, Evans RM, Julien S, Peterson H, Zagoura D, Kadereit S, Gerhard D, Sotiriadou I, Heke M, Natarajan K, Henry M, Winkler J, Marchan R, Stoppini L, Bosgra S, Westerhout J, Verwei M, Vilo J, Kortenkamp A, Hescheler J, Hothorn L, Bremer S, van Thriel C, Krause KH, Hengstler JG, Rahnenführer J, Leist M, Sachinidis A.

Archives of Toxicology,  31 Jan 2013


Effect of developmental dioxin exposure on methylation and expression of specific imprinted genes in mice

Somm E, Stouder C, Paoloni-Giacobino A

Reproductive Toxicology,  31 Jan 2013


Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient.

Lorenzini KI, Calmy A, Ambrosioni J, Assouline B, Daali Y, Fathi M, Rebsamen M, Desmeules J, Samer CF

AIDS (London, England),  16 Nov 2012


Species-specific differences in the inhibition of human and zebrafish 11β-hydroxysteroid dehydrogenase 2 by thiram and organotins

Meyer A, Strajhar P, Murer C, Da Cunha T, Odermatt A

Toxicology,  15 Nov 2012


Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA

Yun J, Adam J, Yerly D, Pichler WJ

Allergy,  1 Nov 2012


Comparison of four drug interaction screening programs

Lorenzini K, Reutemann B, Samer CF, Guignard B, Bonnabry P, Dayer P, Perrier A, Desmeules J, Samer C

Revue médicale suisse,  17 Oct 2012


Virtual screening as a strategy for the identification of xenobiotics disrupting corticosteroid action.

Nashev LG, Vuorinen A, Praxmarer L, Chantong B, Cereghetti D, Winiger R, Schuster D, Odermatt A

PloS one,  12 Oct 2012


Transcriptional regulation of CYP2C19 and its role in altered enzyme activity

Uppugunduri CR, Daali Y, Desmeules J, Dayer P, Krajinovic M, Ansari M

Current drug metabolism,  1 Oct 2012


Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?

van der Poorten D, Samer CF, Ramezani-Moghadam M, Coulter S, Kacevska M, Schrijnders D, Wu LE, McLeod D, Bugianesi E, Komuta M, Roskams T, Liddle C, Hebbard L, George J

Hepatology : official journal of the American Association for the Study of Liver Diseases,  19 Sep 2012


Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers.

Ancrenaz V, Déglon J, Samer C, Staub C, Dayer P, Daali Y, Desmeules J

Basic & clinical pharmacology & toxicology,  21 Aoû 2012